Compass Therapeutics: D. Boral Capital raises Buy rating, PT raised to $30 from $30.

Tuesday, Jan 6, 2026 9:52 am ET1min read
CMPX--

Compass Therapeutics: D. Boral Capital raises Buy rating, PT raised to $30 from $30.

Compass Therapeutics: D. Boral Capital raises Buy rating, PT raised to $30 from $30.

Comments



Add a public comment...
No comments

No comments yet